Octinoxate, Titanium Dioxide, Octocrylene
Generic Name: octinoxate, titanium dioxide, octocrylene
Brand Names:
Age20s Signature Essence Cover Pact Intense Cover 29 Caramel
Sunscreen
Overview
Sunscreen
Uses
■ Helps prevent sunburn. ■ If used as directed with other sun protection measures ( See Directions ), decreases the risk of skin cancer and early skin aging caused by the sun.
Dosage
Directions ■ Apply the product on your skin with the included applicator by rubbing the product with the applicator and gently patting it on your skin.■ Apply liberally 15 minutes before sun exposure. ■ Sun Protection Measures Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: Limit time in the sun, especially from 10a.m. - 2 p.m. ■ Wear long-sleeved shirts, pants, hats, and sunglasses. Children under 6 months of age: Ask a doctor. ■ Reapply at least every 2 hours.■ Use a water-resistant sunscreen if swimming or sweating.
Side Effects
this product ■ keep out of eyes. Rinse with water to remove. and ask a doctor ■ rash occurs.
Warnings
For external use only ■ damaged skin or broken skin
Frequently Asked Questions
What is Octinoxate, Titanium Dioxide, Octocrylene used for?▼
■ Helps prevent sunburn. ■ If used as directed with other sun protection measures ( See Directions ), decreases the risk of skin cancer and early skin aging caused by the sun.
What are the side effects of Octinoxate, Titanium Dioxide, Octocrylene?▼
this product ■ keep out of eyes. Rinse with water to remove. and ask a doctor ■ rash occurs.
What are the important warnings for Octinoxate, Titanium Dioxide, Octocrylene?▼
For external use only ■ damaged skin or broken skin
Related Medications
Anorectal Lidocaine
anorectal lidocaine
Amide Local Anesthetic [EPC]
Purpose Local Anesthetic
Esomeprazole Magnesium Capsule, Delayed Release
esomeprazole magnesium capsule, delayed release
Purpose Acid reducer
Alemtuzumab
alemtuzumab
CD52-directed Cytolytic Antibody [EPC]
11 DESCRIPTION Alemtuzumab, a CD52-directed cytolytic antibody, is a recombinant DNA-derived humanized monoclonal antibody (CAMPATH-1H). CAMPATH-1H is an IgG1 kappa antibody with human variable framework and constant regions, and complementarity-determining regions from a murine (rat) monoclonal antibody (CAMPATH-1G). The CAMPATH-1H antibody has an approximate molecular weight of 150 kD.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.